Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
American Oncology Network Inc (AONCW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
10/29/2025: AONCW (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit 138.04% | Avg. Invested days 19 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/29/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.61 | 52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 |
52 Weeks Range 0.04 - 1.83 | Updated Date 06/8/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.23% | Operating Margin (TTM) 1.7% |
Management Effectiveness
Return on Assets (TTM) -2.38% | Return on Equity (TTM) -30.17% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 8989380 |
Shares Outstanding - | Shares Floating 8989380 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
American Oncology Network Inc
Company Overview
History and Background
American Oncology Network (AON) was founded in 2018. It focuses on community oncology, partnering with practices to enhance patient care and access to services. It has rapidly expanded through partnerships and acquisitions.
Core Business Areas
- Physician Partnership: AON partners with independent oncology practices, providing them with resources and support to improve operations and patient care.
- Ancillary Services: AON offers a range of ancillary services, including pharmacy, lab, and imaging, to support its partner practices.
- Value-Based Care: AON participates in value-based care programs, focusing on improving patient outcomes while reducing costs.
Leadership and Structure
AON is led by a team of experienced healthcare executives and physicians. Its organizational structure is decentralized, allowing partner practices to maintain their autonomy while benefiting from AON's resources.
Top Products and Market Share
Key Offerings
- Practice Management Services: AON provides comprehensive practice management services to its partner practices, including billing, coding, and human resources. Competitors include McKesson, Cardinal Health, and AmerisourceBergen. Market share data is not publicly available for AON's specific service offerings, but practice management is a fragmented market.
- Pharmacy Services: AON operates in-house pharmacies providing oncology medications and related services. Competitors include CVS Specialty and Walgreens. Market share data is not publicly available for AON's specific pharmacy services.
- Clinical Trial Access: AON facilitates access to clinical trials for patients through its network of partner practices. Competitors include research networks affiliated with major academic medical centers and pharmaceutical companies. AON differentiates itself by providing this access within the community oncology setting. AON has a network of 222 physicians.
Market Dynamics
Industry Overview
The oncology market is large and growing, driven by an aging population and advancements in cancer treatment. There is increasing pressure to reduce costs and improve patient outcomes.
Positioning
AON positions itself as a value-added partner for independent oncology practices, helping them to thrive in a changing healthcare landscape. It competes by offering a comprehensive suite of services and a strong network of physicians.
Total Addressable Market (TAM)
The TAM for oncology services in the US is estimated to be hundreds of billions of dollars annually. AON is positioned to capture a portion of this market by partnering with community oncology practices and offering value-based care solutions.
Upturn SWOT Analysis
Strengths
- Strong network of partner practices
- Comprehensive suite of services
- Experienced leadership team
- Focus on value-based care
Weaknesses
- Limited brand recognition outside of its network
- Reliance on partner practices for revenue generation
- Operational complexity due to decentralized structure
Opportunities
- Further expansion through partnerships and acquisitions
- Increased adoption of value-based care models
- Growth in demand for oncology services
- Technological advancement in treatment
Threats
- Increasing competition from larger healthcare organizations
- Changes in reimbursement policies
- Economic downturn impacting patient access to care
- Drug pricing and availability
Competitors and Market Share
Key Competitors
- USON
- McKesson (MCK)
- Cardinal Health (CAH)
Competitive Landscape
AON differentiates itself through its focus on community oncology and its comprehensive suite of services. McKesson and Cardinal Health are larger, more diversified companies. USON is a direct competitor focused on community oncology management.
Major Acquisitions
Genesis Cancer and Blood Institute
- Year: 2021
- Acquisition Price (USD millions):
- Strategic Rationale: Expanded AON's presence in the Southeast and added a strong clinical team.
West Cancer Center & Research Institute
- Year: 2020
- Acquisition Price (USD millions):
- Strategic Rationale: Added a leading cancer center to AON's network, strengthening its research capabilities and clinical expertise.
Growth Trajectory and Initiatives
Historical Growth: American Oncology Network has experienced rapid growth through acquisitions and partnerships since its founding in 2018.
Future Projections: Future growth projections for American Oncology Network are not publicly available.
Recent Initiatives: Recent strategic initiatives include expanding its network of partner practices, launching new value-based care programs, and investing in technology to improve patient care.
Summary
American Oncology Network is a rapidly growing company focused on empowering independent oncology practices. It achieves this by providing resources and services. Financial data is not publicly available so is difficult to assess. While AON has a growing network, it needs to be wary of increasing competition and changes in healthcare regulations. Their ability to implement value-based care programs and leverage technology will be critical to their future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- American Oncology Network website
- Press releases
- Industry reports
- Competitor websites
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Financial data for AON is limited due to its private status. Market share data is based on industry estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Oncology Network Inc
Exchange NASDAQ | Headquaters Fort Myers, FL, United States | ||
IPO Launch date 2021-05-13 | CEO & Director Mr. Todd Schonherz | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 1914 | Website https://www.aoncology.com |
Full time employees 1914 | Website https://www.aoncology.com | ||
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.